In the high-stakes world of biotech and pharma, the challenges never stop. Tariffs disrupt global supply chains. Inflation erodes margins. Recessions tighten R&D budgets and pressure product pipelines. But for companies with a true moat those unique competitive advantages Warren Buffett prizes, these headwinds are opportunities to strengthen position, not retreat.
-
Subscribe
Subscribed
Already have a WordPress.com account? Log in now.
Notable 